Legal
-
Justin Sullivan via Getty Images
23andMe files for bankruptcy; CEO Anne Wojcicki resigns
The DNA-testing company plans to sell its assets after the board rejected an acquisition proposal from Wojcicki.
By Elise Reuter • March 24, 2025 -
Courtesy of Orthofix
Orthofix’s fired execs’ lewd, ‘graphic’ texts surface in legal battle
Orthofix didn’t originally specify the reasons behind the 2023 firing of its CEO, CFO and CLO. Now, a court case is illuminating the story behind the terminations.
By Maura Webber Sadovi • March 10, 2025 -
Stock via Getty Images
FTC challenges $627M private equity takeover of Surmodics
The regulator said the buyout “would lead to a highly concentrated market for outsourced hydrophilic coatings and eliminate significant head-to-head competition.”
By Nick Paul Taylor • March 7, 2025 -
Courtesy of Business Wire
Guardant accuses Natera of poaching employees, stealing trade secrets
The lawsuit claims Natera aggressively recruited bioinformatics scientists from Guardant to “jumpstart its lagging position in the early cancer test industry.”
By Nick Paul Taylor • Updated Feb. 25, 2025 -
Retrieved from Screenshot: The Food and Drug Administration.
Judge orders FDA, health agencies to restore removed webpages
District Judge John Bates wrote the removals harm “everyday Americans, and most acutely, underprivileged Americans, seeking healthcare.”
By Elise Reuter • Feb. 12, 2025 -
Alex Wong via Getty Images
White House rescinds memo pausing federal funding following pushback
The Office of Management and Budget rolled back a memo halting federal funding that caused widespread confusion and alarm. But “this is NOT a rescission of the federal funding freeze,” Trump’s top press secretary said.
By Rebecca Pifer • Jan. 29, 2025 -
Justin Sullivan via Getty Images
Judge halts Trump freeze on grants as states report healthcare payment portals back online
States and providers regained access to a key healthcare payments portal late Tuesday amid widespread backlash over the Trump administration’s decision to halt federal aid.
By Rebecca Pifer • Jan. 29, 2025 -
Adam Pretty/Getty Images via Getty Images
Olympus begins CEO search after Kaufmann resignation
Stefan Kaufmann, former CEO of Tokyo-based Olympus, stepped down in October after the company investigated an allegation that the executive purchased illegal drugs.
By Susan Kelly • Jan. 3, 2025 -
Courtesy of Abbott Laboratories
Abbott, Dexcom settle glucose monitor patent lawsuits
The rival companies agreed not to sue each other for the next 10 years.
By Elise Reuter • Jan. 2, 2025 -
Permission granted by Becton Dickinson
BD to pay $175M to settle charges of misleading investors on Alaris pump
BD will pay a civil penalty to resolve charges it misled investors about risks associated with sales of its Alaris infusion pump, the Securities and Exchange Commission said.
By Elise Reuter • Dec. 17, 2024 -
Chip Somodevilla via Getty Images
How Trump’s second term will affect the medtech industry
From M&A and tariffs to new health leaders, here are the top issues for the medtech industry to watch during President Donald Trump’s return to office.
By Ricky Zipp • Dec. 10, 2024 -
Courtesy of EOFlow
Insulet awarded $452M in EOFlow patent fight
A jury found that competitor EOFlow and former executives misappropriated trade secrets for Insulet’s Omnipod insulin pumps.
By Elise Reuter • Dec. 5, 2024 -
Courtesy of GuardantHealth
Guardant awarded nearly $293M in false ad trial against Natera
Natera allegedly made “false and misleading statements” to convince people to use its Signatera cancer test rather than Guardant’s rival product Reveal.
By Nick Paul Taylor • Dec. 2, 2024 -
Win McNamee/Getty Images via Getty Images
Advamed CEO congratulates Trump, stresses need for public policy support
Donald Trump’s election victory comes weeks after the FDA named a new leader for the medical device center and as the agency’s contentious LDT final rule is challenged in court.
By Ricky Zipp • Nov. 11, 2024 -
Wavebreakmedia via Getty Images
Medtronic settles pulse oximetry lawsuit alleging inaccuracies
Roots Community Health has sued 12 other firms, including GE Healthcare, CVS and Walgreens, and called for manufacturers and the FDA to ensure the devices work for everyone.
By Elise Reuter • Nov. 4, 2024 -
GussWilder for iStock via Getty Images
Exactech files for Chapter 11, agrees to investor buyout
The filing follows Exactech’s failure to settle product liability claims from about 2,600 patients in response to recalls of orthopedic devices.
By Nick Paul Taylor • Oct. 30, 2024 -
RiverNorthPhotography via Getty Images
FTC increases premerger reporting requirements over provider objections
Companies will be required to disclose more information about minority investors and past M&A activity. Provider groups said the new requirements would be burdensome for hospitals.
By Susanna Vogel • Oct. 16, 2024 -
Patrik Stollarz / Staff via Getty Images
Independent lab fires back after Philips sues over testing results
PSN Labs called for a jury trial, claiming Philips is attempting to deflect attention away from its own “failures, negligence, concealment and recklessness.”
By Elise Reuter • Oct. 3, 2024 -
Permission granted by Becton Dickinson
BD agrees to settle most of its hernia mesh litigation
The settlement terms are confidential, BD said. The company disputes the lawsuit’s allegations and backs its product designs.
By Susan Kelly • Oct. 3, 2024 -
Stock Photo via Getty Images
Jury sides with Axonics in Medtronic patent dispute
Meanwhile, Boston Scientific is still waiting for antitrust regulators to conclude their review of its proposal to buy Axonics, which was announced in January.
By Elise Reuter • Sept. 19, 2024 -
Courtesy of BusinessWire/Masimo
Masimo proxy fight nears end as shareholder vote looms
Chairman and CEO Joe Kiani’s board seat is on the line at today's shareholder meeting.
By Susan Kelly • Sept. 19, 2024 -
Samuel Corum via Getty Images
Illumina court ruling limits EU regulators’ merger review power
The European Commission lacked oversight authority to examine the proposed sale of a cancer-detection company to biotech company Illumina, the court found.
By Justin Bachman • Sept. 9, 2024 -
Mario Tama via Getty Images
Judge orders J&J to pay Auris investors more than $1B for merger violations
J&J did not provide Auris Health with resources to achieve regulatory milestones after acquiring the robotics company in 2019, the judge found.
By Ricky Zipp • Sept. 6, 2024 -
Courtesy of Grail
Illumina avoids fine for Grail purchase in European court victory
Illumina will avoid a penalty of 432 million euros after a court ruled the European Commission did not have jurisdiction to challenge the company’s Grail acquisition.
By Susan Kelly • Sept. 3, 2024 -
andresr via Getty Images
Pathology group sues to block FDA lab test rule
The Association for Molecular Pathology is the second lab trade group urging the courts to void an FDA policy expanding oversight of diagnostic tests.
By Susan Kelly • Aug. 30, 2024
